We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-7.28%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.53B
AUM Growth
-$382M
Cap. Flow
+$195M
Cap. Flow %
2.99%
Top 10 Hldgs %
59.37%
Holding
305
New
83
Increased
54
Reduced
76
Closed
50

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$108M
2
BUD icon
AB InBev
BUD
+$39.8M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$33.9M
4
CRL icon
Charles River Laboratories
CRL
+$32M
5
CL icon
Colgate-Palmolive
CL
+$27M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$93.3M
2
PFE icon
Pfizer
PFE
+$76.9M
3
JNJ icon
Johnson & Johnson
JNJ
+$53.7M
4
INCY icon
Incyte
INCY
+$46.6M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$45.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.38%
2 Consumer Staples 6.6%
3 Technology 4.23%
4 Consumer Discretionary 3.89%
5 Communication Services 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDHL
176
Redhill Biopharma
RDHL
$4.07M
$369K 0.01%
+28,916
New +$756K
HLT icon
177
Hilton Worldwide
HLT
$72.5B
$356K 0.01%
2,371
-37,629
-94% -$5.68M
ADTX
178
DELISTED
ADITXT INC
ADTX
– –
0
– –
PRSO icon
179
Peraso
PRSO
$10.8M
$317K ﹤0.01%
42,250
-17,775
-30% -$240K
SCNI
180
Scinai Immunotherapeutics
SCNI
$1.19M
$315K ﹤0.01%
+36,245
New +$465K
SBFM
181
Sunshine Biopharma
SBFM
$3.47M
$312K ﹤0.01%
49
-61
-55% -$546K
WING icon
182
Wingstop
WING
$3.25B
$309K ﹤0.01%
+1,720
New +$297K
POOL icon
183
Pool Corp
POOL
$7.37B
$309K ﹤0.01%
+868
New +$316K
LUV icon
184
Southwest Airlines
LUV
$23.1B
$295K ﹤0.01%
+10,880
New +$355K
MKUL
185
DELISTED
Molekule Group, Inc. Common Stock
MKUL
$281K ﹤0.01%
1,937,949
-1,361,926
-41% -$2.02M
SPCB icon
186
SuperCom
SPCB
$66.4M
$277K ﹤0.01%
33,050
+14,862
+82% +$200K
CFRX
187
DELISTED
ContraFect Corporation
CFRX
$271K ﹤0.01%
475,000
+419,258
+752% +$397K
BYD icon
188
Boyd Gaming
BYD
$6.11B
$260K ﹤0.01%
+4,273
New +$285K
IKT icon
189
Inhibikase Therapeutics
IKT
$375M
$259K ﹤0.01%
186,046
-310,501
-63% -$696K
MOTS
190
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$255K ﹤0.01%
37,800
+19,601
+108% +$163K
K
191
DELISTED
Kellanova
K
$250K ﹤0.01%
+4,474
New +$266K
STAF
192
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
$244K ﹤0.01%
+35,883
New +$274K
AEO icon
193
American Eagle Outfitters
AEO
$2.99B
$240K ﹤0.01%
+14,478
New +$214K
AGRX
194
DELISTED
Agile Therapeutics
AGRX
$235K ﹤0.01%
98,000
-24,000
-20% -$59.1K
GNLN icon
195
Greenlane Holdings
GNLN
$1.23M
$234K ﹤0.01%
5
+4
+400% +$230K
NCLH icon
196
Norwegian Cruise Line
NCLH
$9.06B
$224K ﹤0.01%
+13,609
New +$251K
RBLX icon
197
Roblox
RBLX
$26.3B
$221K ﹤0.01%
+7,626
New +$253K
BCE icon
198
BCE
BCE
$21.3B
$219K ﹤0.01%
+5,729
New +$241K
RCI icon
199
Rogers Communications
RCI
$18.6B
$208K ﹤0.01%
+5,409
New +$227K
ADXN
200
Addex Therapeutics
ADXN
$7.18M
$206K ﹤0.01%
26,850
+13,650
+103% +$138K
6 7
8
9 10

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Armistice Capital held 305 positions worth $6.53B, down 5.5% from $6.91B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Armistice Capital's Q3 2023 filing shows 83 new, 54 increased, 76 reduced and 50 closed positions. Its largest new stake was AB InBev: 703,000 shares worth $38.9M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $93.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 39% a quarter earlier, followed by Consumer Staples and Technology.

  • Armistice Capital's largest Q3 2023 buy was AB InBev: 703,000 shares worth $38.9M.
  • Armistice Capital added most to PTC Therapeutics in Q3 2023, an estimated $108M increase.
  • Armistice Capital's biggest Q3 2023 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $93.3M.
  • Armistice Capital fully exited Pfizer in Q3 2023, selling an estimated $76.9M.
  • Armistice Capital's ten largest holdings make up 59% of its $6.53B portfolio in Q3 2023.
  • Armistice Capital opened 83 new positions and closed 50 in Q3 2023.
  • Armistice Capital's portfolio value fell 5.5% quarter-over-quarter to $6.53B.

Based on Armistice Capital's 13F filing for Q3 2023, filed 14 Nov 2023.